SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 209 filers reported holding SAGE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $282 | -99.9% | 7,405 | -17.4% | 0.01% | -14.3% |
Q3 2022 | $351,000 | -3.8% | 8,961 | -20.8% | 0.01% | +27.3% |
Q2 2022 | $365,000 | -2.4% | 11,309 | +0.2% | 0.01% | +22.2% |
Q1 2022 | $374,000 | -32.1% | 11,291 | -12.9% | 0.01% | -18.2% |
Q4 2021 | $551,000 | +21.4% | 12,963 | +26.5% | 0.01% | +10.0% |
Q3 2021 | $454,000 | -25.2% | 10,251 | -4.1% | 0.01% | -16.7% |
Q2 2021 | $607,000 | -19.8% | 10,691 | +5.7% | 0.01% | -20.0% |
Q1 2021 | $757,000 | +99.2% | 10,111 | +130.4% | 0.02% | +87.5% |
Q4 2020 | $380,000 | +41.8% | 4,388 | 0.0% | 0.01% | +33.3% |
Q3 2020 | $268,000 | +47.3% | 4,388 | 0.0% | 0.01% | +20.0% |
Q2 2020 | $182,000 | +42.2% | 4,388 | -1.9% | 0.01% | +25.0% |
Q1 2020 | $128,000 | -61.0% | 4,473 | -1.5% | 0.00% | -42.9% |
Q4 2019 | $328,000 | -50.0% | 4,543 | -2.8% | 0.01% | -53.3% |
Q3 2019 | $656,000 | -24.0% | 4,675 | -0.8% | 0.02% | -21.1% |
Q2 2019 | $863,000 | +12.5% | 4,715 | -2.3% | 0.02% | +11.8% |
Q1 2019 | $767,000 | +230.6% | 4,824 | +99.3% | 0.02% | +183.3% |
Q4 2018 | $232,000 | -37.3% | 2,420 | -7.6% | 0.01% | -14.3% |
Q3 2018 | $370,000 | -9.8% | 2,620 | 0.0% | 0.01% | -12.5% |
Q2 2018 | $410,000 | -6.4% | 2,620 | -3.7% | 0.01% | -11.1% |
Q1 2018 | $438,000 | – | 2,720 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 1,966,688 | $120,204,000 | 10.81% |
Integral Health Asset Management, LLC | 230,000 | $14,058,000 | 4.30% |
Asymmetry Capital Management, L.P. | 102,462 | $6,262,000 | 4.02% |
ACUTA CAPITAL PARTNERS, LLC | 225,000 | $13,752,000 | 3.74% |
DAFNA Capital Management LLC | 158,306 | $9,676,000 | 3.14% |
Bain Capital Life Sciences Investors, LLC | 499,100 | $30,505,000 | 2.84% |
Boxer Capital, LLC | 1,094,000 | $66,865,000 | 2.31% |
Palo Alto Investors LP | 590,200 | $36,073,000 | 1.98% |
Logos Global Management LP | 250,000 | $15,280,000 | 1.96% |
Bellevue Group AG | 1,579,504 | $96,539,000 | 1.33% |